Parkin (encoded by the PRKN gene, formerly PARK2) is a neuron-specific E3 ubiquitin ligase that plays a critical role in mitochondrial quality control through mitophagy. Mutations in PRKN cause autosomal recessive early-onset Parkinson's disease (PD), making Parkin-expressing neurons particularly vulnerable to mitochondrial dysfunction.
Parkin (PRKN) Neurons represent a specialized population of neurons that rely heavily on the PINK1-Parkin mitophagy pathway for mitochondrial maintenance. These neurons are particularly abundant in the substantia nigra pars compacta (SNc), striatum, and frontal cortex — regions severely affected in Parkinson's disease. [1]
The loss of Parkin function leads to accumulation of dysfunctional mitochondria, increased reactive oxygen species (ROS), and progressive neuronal death. Understanding Parkin-expressing neurons is essential for developing therapeutic interventions targeting mitochondrial dysfunction in neurodegenerative disorders. [2]
Parkin is widely expressed throughout the central nervous system, with highest expression in: [3]
Parkin subcellular distribution in neurons: [4]
Parkin regulates multiple aspects of mitochondrial biology: [5]
| Process | Role |
|---|---|
| Mitophagy | Tags damaged mitochondria for autophagic clearance |
| Mitochondrial biogenesis | Coordinates with PGC-1α for new mitochondria |
| mitochondrial transport | Maintains mitochondrial distribution in neurites |
| Synaptic maintenance | Quality controls synaptic mitochondria |
The PINK1-Parkin pathway is the primary mechanism for mitochondrial quality control in neurons: [6]
Mitochondrial damage sensing: Under basal conditions, PINK1 (PTEN-induced kinase 1) is imported into healthy mitochondria and degraded.
Parkin recruitment: Upon mitochondrial damage (e.g., ROS, membrane potential loss), PINK1 accumulates on the outer mitochondrial membrane.
Parkin activation: PINK1 phosphorylates Parkin at Ser65 and ubiquitin, activating Parkin's E3 ligase activity.
Substrate ubiquitination: Activated Parkin ubiquitinates mitochondrial outer membrane proteins including:
Mitophagy execution: Ubiquitinated mitochondria are recognized by autophagic receptors (p62, NDP52, OPTN) and delivered to lysosomes.
Parkin has diverse substrate specificity: [7]
Parkin mutations are the most common cause of autosomal recessive early-onset PD: [8]
The loss of Parkin function leads to: [9]
Parkin dysfunction contributes to: [10]
Targeting the Parkin pathway: [11]
Key experimental approaches: [12]
Pickrell AM, et al. The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson's Disease. Neuron (2015). 2015. ↩︎
Narendra DP, et al. p62/SQSTM1 is required for Parkin-induced mitochondrial turnover but is not necessary for PINK1/Parkin-mediated mitophagy. Autophagy (2016). 2016. ↩︎
Dawson TM, Dawson VL. The role of parkin in Parkinson's disease and neurodegeneration. Ann Neurol (2010). 2010. ↩︎
Yamano K, et al. How do mitofusins and other outer membrane proteins work in mitochondrial dynamics? J Biochem (2018). 2018. ↩︎
McWilliams TG, Muqit MM. PINK1 and Parkin: emerging themes in mitochondrial homeostasis. Curr Opin Cell Biol (2017). 2017. ↩︎
Kondapalli C, et al. PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by initializing Parkin recruitment to damaged mitochondria. Nat Cell Biol (2012). 2012. ↩︎
Harper JW, et al. Construction of a ubiquitin-proteasome system for the regulated degradation of cellular proteins. J Mol Biol (2019). 2019. ↩︎
Lücking CB, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med (2000). 2000. ↩︎
Corti O, et al. The molecular genetics of parkin: overview and new insights. Brain (2021). 2021. ↩︎
Van Laar VS, Berman SB. The interplay of neuronal mitochondrial dysfunction and mitochondrial dynamics in Alzheimer's disease and Parkinson's disease. Exp Neurol (2019). 2019. ↩︎
Swanenson S, et al. Novel therapeutic strategies for Parkinson's disease: targeting mitochondrial dysfunction and neuroinflammation. Nat Rev Drug Discov (2022). 2022. ↩︎
Cai Q, et al. Studying mitophagy in neurons: Using fluorescent mitophagy reporters. Methods Mol Biol (2020). 2020. ↩︎